Raymond James Financial Inc. Invests $14.51 Million in TG Therapeutics, Inc. (NASDAQ:TGTX)
Raymond James Financial Inc. acquired a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 481,989 shares of the biopharmaceutical company’s stock, valued at approximately $14,508,000. Several other institutional investors and hedge funds have also […]
